Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
ResMed Inc.
Type
Public
Traded as
  • NYSE: RMD
  • S&P 500 component
Industry Medical
Founded 1989
Founder Peter C. Farrell
(Founder and Chairman)
Headquarters San Diego, California
Key people
Michael "Mick" Farrell
(CEO)
Robert Douglas
(President and COO)
Products Medical equipment for sleep-disordered breathing and other respiratory disorders
Website resmed.com

ResMed is a global manufacturer of CPAP masks, machines and other products that diagnose, treat or help manage sleep-disordered breathing (particularly sleep apnea), chronic obstructive pulmonary disease (COPD), or other respiratory conditions. For the general public, the company offers a non-contact sleep monitor, the S+ by ResMed, currently available in the US.

ResMed employs about 5,000 employees worldwide, operates in 100 countries and has manufacturing facilities in Australia, France, Singapore and the US. It achieved revenues of $1.7 billion USD in fiscal year 2014–15.

As part of its mission, ResMed seeks to spread awareness of the prevalence of sleep-disordered breathing (SDB) and its major manifestation, obstructive sleep apnea (OSA), since more than 80% of cases are believed to be undiagnosed. More than 70% of people with obesity, heart failure, type 2 diabetes, and drug-resistant hypertension have some form of sleep-disordered breathing.

In 1980, Professor Colin Sullivan invented the first continuous positive airway pressure (CPAP) machine, regarded today as the “gold standard” in sleep apnea treatment. ResMed launched in 1989 when founder Peter Farrell sought to expand the general public’s access to CPAP treatment. The company was founded in Australia in 1989, but relocated to San Diego in 1990. In addition to CPAP machines and masks, the company has since grown to produce CPAP humidifiers, heated tubes and other accessories, as well as diagnostic tools, hospital CPAP machines and life support ventilators. It has also expanded into healthcare informatics, with software solutions that enable patients and medical professionals to wirelessly monitor sleep data.

Investment goal date:
Dividends reinvested
ResMed Inc. RMD report Q1 2018
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q3 2018
2018-04-25
--
--
Q2 2018
2018-01-22
--
--
Q1 2018
2017-10-26
0.6600
0.6000
Q4 2017
2017-08-01
0.7700
0.7100
Q3 2017
2017-04-27
0.7100
0.6200
Q2 2017
2017-01-23
0.7300
0.5400
Q1 2017
2016-10-25
0.6200
0.5400
Q4 2016
2016-07-28
0.7400
0.5900
Q3 2016
2016-04-26
0.6800
0.6400
Q2 2016
2016-01-21
0.6900
0.6800
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BAILLIE GIFFORD & CO
4939074
Bank of New York Mellon Corp
2240738
BlackRock Fund Advisors
6174597
BlackRock Group LTD
935885
BlackRock Inc.
13335138
BlackRock Institutional Trust Company, N.A.
4566701
Capital World Investors
10226707
COMMONWEALTH BANK OF AUSTRALIA
1981508
FMR LLC
4010810
GEODE CAPITAL MANAGEMENT, LLC
1176810
GOLDMAN SACHS GROUP INC
1017826
MORGAN STANLEY
1344234
NORTHERN TRUST CORP
1355497
STATE STREET CORP
4598911
Vanguard Group, Inc
11535707
Major Shareholders
Name Relationship
Total Shares
Holding stocks
TAYLOR RONALD R
0.0100% (19216)
ACT / RLH / RMD /
PACE GARY W
0.0700% (97587)
PCRX / RMD /
FARRELL PETER C
0.2100% (292942)
NUVA / RMD /
FARRELL PETER C
0.2100% (294800)
NUVA / RMD /
ROBERTS CHRISTOPHER G
0.1600% (224337)
RMD /
QUINN MICHAEL A
0.2000% (287000)
RMD /
PENDARVIS DAVID
0.0600% (90788)
RMD / SQNM /
PENDARVIS DAVID
0.0700% (94203)
RMD / SQNM /
WAREHAM JOHN P
0.0100% (13000)
RMD / STE /
Sandercock Brett
0.0500% (71772)
RMD /
Sandercock Brett
0.0500% (73022)
RMD /
Douglas Robert Andrew
0.0400% (53789)
RMD /
Douglas Robert Andrew
0.0500% (65600)
RMD /
Farrell Michael J.
0.1500% (211065)
RMD / ZMH /
Farrell Michael J.
0.1700% (232732)
RMD / ZMH /
Darkin Donald
0.0100% (13684)
RMD /
Burt Carol
0.0100% (14220)
EVHC / RMD / WCG /
Reiser Anne
0.0600% (90711)
RMD /
Hollingshead James
0.0400% (59390)
RMD /
Hollingshead James
0.0500% (65471)
RMD /
Sodhi Rajwant
0.0200% (26521)
RMD /
Sodhi Rajwant
0.0300% (36008)
RMD /
McHale Richard
0.0100% (11995)
RMD /
% ()